am 580 has been researched along with Kidney Diseases in 1 studies
Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, Y | 1 |
| Wu, Y | 1 |
| Liu, R | 1 |
| Li, Z | 1 |
| Chen, Y | 1 |
| Evans, T | 1 |
| Chuang, P | 1 |
| Das, B | 1 |
| He, JC | 1 |
1 other study available for am 580 and Kidney Diseases
| Article | Year |
|---|---|
Novel retinoic acid receptor alpha agonists for treatment of kidney disease.
Topics: AIDS-Associated Nephropathy; Animals; Benzoates; Benzopyrans; Binding, Competitive; Body Weight; Bor | 2011 |